AI-generated summary
The authors studied red (655 nm) and near-infrared (808 nm) light therapy applied to 3D scaffold-free microtissues made from human bone marrow stem cells and endothelial cells, to see whether it promoted bone-forming differentiation. They report that both wavelengths preserved cell viability, and that 1 and 5 J/cm2 changed diameter and signaling molecule levels compared with controls. The authors conclude that the therapy induced osteogenesis, though the abstract describes this as an in vitro study.
- Who or what was studied
- Human bone marrow stem cells and human umbilical vein endothelial cells cultured as scaffold-free 3D microtissues (in vitro)
- Wavelengths
- 655, 808 nm
- Limits stated in the abstract
- The study was performed on cultured cells in vitro, not in humans or animals, and the abstract does not report statistical details or clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 655 nm, 808 nm
- Energy density (fluence)
- 5 J/cm2, 1 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Photobiomodulation therapy, Reactive oxygen species, Adenosine triphosphate, Wavelength, Control group, Mitochondria. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.